Initially identified as a respiratory illness, COVID-19 has increasingly been linked to a range of neurologic complications, including myelitis, acute disseminated encephalomyelitis, and Guillain-Barré syndrome. Potential signals of central nervous system involvement-either during active infection or in the postinfectious period-include ataxia and cognitive changes. Though rarely observed in the setting of COVID-19 infection, these neurologic symptoms can be serious, and therefore, providers should maintain a high index of suspicion for central nervous system involvement in patients with current or recent COVID-19 infection. This article presents a rare case of concurrent cerebellitis and corpus callosum cytotoxicity after SARS-CoV-2 infection.
Johnson et al. (Thu,) studied this question.